Abstract
dc:descriptionGroup B Streptococcus (GBS) and SARS-CoV-2 represent significant respiratory pathogens with severe consequences for neonates and vulnerable individuals. GBS is a leading cause of neonatal pneumonia, sepsis, and meningitis, exploiting the immaturity of the neonatal immune system to invade the bloodstream. Despite its clinical significance, little is known about the role of alveolar epithelial cells in mounting an effective defense against GBS. In this study, we investigate the potential for enhancing alveolar epithelial cell-mediated immune responses against GBS through inhibition of the Akt kinase pathway. Our findings demonstrate that Akt inhibition enhances bacterial clearance via the induction of autophagy, increases inflammatory mediator production, and reduces both extracellular and intracellular bacterial loads. These mechanisms collectively strengthen the epithelial barrier and limit GBS invasion into the bloodstream, providing a novel therapeutic target for neonatal GBS infections. In parallel, the global SARS-CoV-2 pandemic has underscored the devastating impact of viral infections on pulmonary immune responses, particularly through the development of acute respiratory distress syndrome (ARDS) and cytokine storm. Our research focuses on the immunomodulatory effects of the SARS-CoV-2 spike (S) protein on macrophages and alveolar epithelial cells. We demonstrate that that SARS-CoV-2 promoted inflammatory cytokine expression and suppressed IRAK-M, rendering macrophages prone to increased responsiveness to TLR signals, supporting the development of cytokine storm observed in COVID-19 patients. Moreover, our findings may propose the use of Diminazene Aceturate (ACE2 activator) as a potential treatment for patients with COVID-19, since it is may reverse the pro-inflammatory actions of the virus. Conversely, in alveolar epithelial type II cells, SARS-CoV-2 S protein suppressed inflammatory responses at early stages of infection through activation of the PI3K/AKT pathway. These results suggest that at early stages SARS-CoV-2 S protein signals inhibit immune responses to the virus allowing it to propagate the infection while in combination with TLR2 signals enhances PAI-1 expression, potentially affecting the local coagulation cascade.Collectively, our findings highlight critical mechanisms by which alveolar epithelial cells and macrophages respond to GBS and SARS-CoV-2 infections. The modulation of Akt signaling in GBS infection and ACE2 activation in SARS-CoV-2 infection emerge as promising therapeutic strategies. Understanding these pathogen-specific immune interactions provides valuable insights for developing targeted interventions to mitigate severe respiratory infections and improve patient outcomes.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pantazi, Ioanna
- Πανταζή, Ιωάννα
Subjects
dc:subject × 18- Στρεπτόκοκκος ομάδας Β (GBS)
- Κορονοϊός
- Κυψελίδες πνεύμονα
- Μακροφάγα
- ΑΚΤ κινάση
- IRAK-Μ
- Group beta streptococcus (GBS)
- SARS-CoV-2
- Alveolar epithelial cells
- Macrophages
- AKT kinase
- IRAK M kinase
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Health Sciences
- Medical and Health Sciences
- Infectious Diseases
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60452